Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"

被引：0
|
作者：
Radtke, Jan Philipp [1 ,2 ]
Albers, Peter [3 ]
Giesel, Frederik Lars [4 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Klin Urol, Dusseldorf, Germany
[2] Deutsch Krebsforschungszentrum, Abt Radiol, Heidelberg, Germany
[3] Univ Klinikum Dusseldorf, Klin Urol, Dusseldorf, Germany
[4] Univ Dusseldorf, Klin Nukl Med, Nukl Med, Dusseldorf, Germany
来源：
AKTUELLE UROLOGIE | 2022年 / 53卷 / 02期
关键词：
THERAPY;
D O I：
10.1055/a-1707-6928
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] 177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer patients with a single functioning kidney
    Zhang, Jingjing
    Kulkarni, Harshad
    Singh, Aviral
    Schuchardt, Christiane
    Niepsch, Karin
    Langbein, Thomas
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [22] Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
    Mehrens, Dirk
    Kramer, Kristina K. M.
    Unterrainer, Lena M.
    Beyer, Leonie
    Bartenstein, Peter
    Froelich, Matthias F.
    Tollens, Fabian
    Ricke, Jens
    Ruebenthaler, Johannes
    Schmidt-Hegemann, Nina-Sophie
    Herlemann, Annika
    Unterrainer, Marcus
    Kunz, Wolfgang G.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01): : 43 - +
  • [23] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
    Braeuer, Axel
    Grubert, Lena Sophie
    Roll, Wolfgang
    Schrader, Andres Jan
    Schaefers, Michael
    Boegemann, Martin
    Rahbar, Kambiz
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1663 - 1670
  • [24] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
    Axel Bräuer
    Lena Sophie Grubert
    Wolfgang Roll
    Andres Jan Schrader
    Michael Schäfers
    Martin Bögemann
    Kambiz Rahbar
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1663 - 1670
  • [25] Combined 177Lu-PSMA-617 PRLT and abiraterone acetate versus 177Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability
    Suman, Sonam
    Parghane, Rahul V.
    Joshi, Amit
    Prabhash, Kumar
    Talole, Sanjay
    Basu, Sandip
    PROSTATE, 2021, 81 (15): : 1225 - 1234
  • [26] Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
    Herrmann, Ken
    Rahbar, Kambiz
    Eiber, Matthias
    Sparks, Richard
    Baca, Nicholas
    Krause, Bernd J.
    Lassmann, Michael
    Jentzen, Walter
    Tang, Jun
    Chicco, Daniela
    Klein, Patrick
    Blumenstein, Lars
    Basque, Jean-Rene
    Kurth, Jens
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (01) : 71 - 78
  • [27] Excellent Response to Lower Dose of 177Lu-PSMA-617 in a Metastatic Castration-Resistant Prostate Cancer Patient With a Transplanted Kidney
    Norouzi, Ghazal
    Aghdam, Ramin Akbarian
    Hashemifard, Hamidreza
    Pirayesh, Elahe
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : 483 - 484
  • [28] Influence of short-term dexamethasone on the efficacy of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Derlin, Thorsten
    Sohns, Jan M. Sommerlath
    Schmuck, Sebastian
    Henkenberens, Christoph
    von Klot, Christoph A. J.
    Ross, Tobias L.
    Bengel, Frank M.
    PROSTATE, 2020, 80 (08): : 619 - 631
  • [29] 177Lu-PSMA-617 for metastatic prostate cancer in India
    Ghose, Aruni
    Banerjee, Soirindhri
    Choudhury, Partha S.
    Maniam, Akash
    Gupta, Manoj
    Banna, Giuseppe L.
    Vasdev, Nikhil
    Ghose, Amit
    Noronha, Vanita
    Mitra, Swarupa
    LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 30
  • [30] Combination of 177Lu-PSMA-617 and External Radiotherapy for the Treatment of Cerebral Metastases in Patients With Castration-Resistant Metastatic Prostate Cancer
    Wei, Xiao
    Schlenkhoff, Carl
    Schwarz, Bettina
    Essler, Markus
    Ahmadzadehfar, Hojjat
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (09) : 704 - 706
12345